Patients with hereditary factor viii deficiency receiving recombinate [antihemophilic factor (recombinant)] (ndc: 00944-2845-10, lot: tra22806aa, iu: 2080) reporting plastic particles in the baxject ii device.After reconstitution, shards of plastic are also found within the injection syringe/reconstituted solution which is administered intravenously.It only seems to be appearing in this specific lot number and it is sporadic.Two patients have reported this to us so far.Manufacture has been notified.Reference report: mw5118299.
|
Additional information received from reporter on 01-nov-2023, for mw5118298.Patient contacted an employee of (b)(6) pharmacy, inc.And sent photos of the medication syringe which contained shards of plastic in the medication solution.This was already reported and resulted in a voluntary recall of the baxject ii device.This was reported after the voluntary recall on 08/28/2023.
|